Skip to main content
. Author manuscript; available in PMC: 2010 Jun 1.
Published in final edited form as: Crit Care Med. 2009 Jun;37(6):1978–1987. doi: 10.1097/CCM.0b013e31819feb4d

Figure 8.

Figure 8

Effect of treatment with 15d-PGJ2 (0.5 mg/kg i.p.) on lung DNA binding of PPARγ (A), NF-κB (B) and HSF-1 as determined by densitometry from EMSA autoradiographs. Fold increase was calculated versus respective sham value (time 0) set to 1.0. Each data point represents the mean ± SEM of 3 separate time-course experiments. *Represents p < .05 versus young rats. #Represents p < .05 versus vehicle-treated rats.